F. Ivy Carroll

9.6k total citations
305 papers, 8.0k citations indexed

About

F. Ivy Carroll is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, F. Ivy Carroll has authored 305 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 187 papers in Molecular Biology, 152 papers in Cellular and Molecular Neuroscience and 89 papers in Organic Chemistry. Recurrent topics in F. Ivy Carroll's work include Receptor Mechanisms and Signaling (112 papers), Neurotransmitter Receptor Influence on Behavior (106 papers) and Neuroscience and Neuropharmacology Research (84 papers). F. Ivy Carroll is often cited by papers focused on Receptor Mechanisms and Signaling (112 papers), Neurotransmitter Receptor Influence on Behavior (106 papers) and Neuroscience and Neuropharmacology Research (84 papers). F. Ivy Carroll collaborates with scholars based in United States, United Kingdom and France. F. Ivy Carroll's co-authors include Michael J. Kuhar, Anita H. Lewin, Hernán A. Navarro, S. Wayne Mascarella, Leonard L. Howell, Philip Abraham, James L. Howard, Bruce E. Blough, M. Imad Damaj and John W. Boja and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

F. Ivy Carroll

297 papers receiving 7.8k citations

Peers

Countries citing papers authored by F. Ivy Carroll

Since Specialization

Citations

This map shows the geographic impact of F. Ivy Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Ivy Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Ivy Carroll more than expected).

Fields of papers citing papers by F. Ivy Carroll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Ivy Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Ivy Carroll. The network helps show where F. Ivy Carroll may publish in the future.

Co-authorship network of co-authors of F. Ivy Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of F. Ivy Carroll. A scholar is included among the top collaborators of F. Ivy Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Ivy Carroll. F. Ivy Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives 2020 ·Molecular Pharmacology ·Lu Wen-Chi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance Richard McMahon, Roger L. Papke	8
2	Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of the 3- and 4-methyl substituents 2015 ·Bioorganic & Medicinal Chemistry ·F. Ivy Carroll, (unknown), Chad M. Kormos, Rangan Maitra, Scott P. Runyon, James B. Thomas, S. Wayne Mascarella, Ann M. Decker, Hernán A. Navarro	14
3	The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety 2012 ·Addiction Biology ·Jesse R. Schank, (unknown), (unknown), Courtney King, Julie A. Marusich, Jenny L. Wiley, F. Ivy Carroll, Annika Thorsell, Markus Heilig	85
4	Hydrolytic instability of the important orexin 1 receptor antagonist SB-334867: Possible confounding effects on in vivo and in vitro studies 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Anita H. Lewin, S. Wayne Mascarella, Scott P. Runyon, Lawrence E. Brieaddy, F. Ivy Carroll	47
5	Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats 2011 ·Neuropharmacology ·Luping Z. Huang, Carla Cristian Campos, (unknown), F. Ivy Carroll, Maryka Quik	59
6	Positive allosteric modulation of the human cannabinoid (CB ₁ ) receptor by RTI‐371, a selective inhibitor of the dopamine transporter 2009 ·British Journal of Pharmacology ·Hernán A. Navarro, James L. Howard, Gerald T. Pollard, F. Ivy Carroll	70
7	Synthesis and structure–activity relationship of 3β-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3β-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters 2009 ·Bioorganic & Medicinal Chemistry ·Chunyang Jin, Hernán A. Navarro, F. Ivy Carroll	5
8	From rapid In Vitro screening to rapid In Vivo screening in the drug discovery process 2008 ·Neuropsychopharmacology ·F. Ivy Carroll, Richard A. Houghten	9
9	Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats 2005 ·Psychopharmacology ·Patrick M. Beardsley, James L. Howard, Keith L. Shelton, F. Ivy Carroll	243
10	Effects of Dopamine Transporter Inhibitors on Cocaine Self-Administration in Rhesus Monkeys: Relationship to Transporter Occupancy Determined by Positron Emission Tomography Neuroimaging 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Kimberly P. Lindsey, Kristin M. Wilcox, John R. Votaw, Mark M. Goodman, Christophe Plisson, F. Ivy Carroll, Kenner C. Rice, Leonard L. Howell	54
11	Epibatidine structure–activity relationships 2004 ·Bioorganic & Medicinal Chemistry Letters ·F. Ivy Carroll	53
12	Distinct Molecular Recognition of Psychostimulants by Human and Drosophila Serotonin Transporters 2004 ·Journal of Pharmacology and Experimental Therapeutics ·David L. Roman, Shannon N. Saldaña, David E. Nichols, F. Ivy Carroll, Eric L. Barker	8
13	Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats 2001 ·International Immunopharmacology ·Kelly Byrnes-Blake, F. Ivy Carroll, Philip Abraham, S. Michael Owens	58
14	Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission 2000 ·Journal of Neuroscience Nursing ·(unknown), F. Ivy Carroll, MJ Kuhar, (unknown), (unknown)	43
15	Methamphetamine Dependence: Medication Development Efforts Based on the Dual Deficit Model of Stimulant Addiction 2000 ·Annals of the New York Academy of Sciences ·Richard B. Rothman, John S. Partilla, Christina M. Dersch, F. Ivy Carroll, Kenner C. Rice, Michael H. Baumann	16
16	Opioid peptide receptor studies, 11: Involvement of Tyr148, Trp318 and His319 of the rat ?-opioid receptor in binding of ?-selective ligands 1999 ·Synapse ·Heng Xu, Yifeng Lu, John S. Partilla, (unknown), Jiabei Wang, George A. Brine, F. Ivy Carroll, Kenner C. Rice, Kaixian Chen, (unknown), (unknown)	41
17	Ohmefentanyl and Its Stereoisomers: Chemistry and Pharmacology 1997 ·Current Medicinal Chemistry ·George A. Brine, F. Ivy Carroll, (unknown), H. Eric Xu, (unknown)	10
18	Synthesis and characterization of [125I]3′-(−)-iodopentazocine, a selective σ1 receptor ligand 1997 ·European Journal of Pharmacology ·Chih‐Cheng Chien, F. Ivy Carroll, George P. Brown, (unknown), Wayne D. Bowen, Gavril W. Pasternak	9
19	[¹²⁵I]RTI‐55 Binding to Cocaine‐Sensitive Dopaminergic and Serotonergic Uptake Sites in the Human Brain 1993 ·Journal of Neurochemistry ·Karley Y. Little, (unknown), F. Ivy Carroll, George R. Breese, Gary E. Duncan	49
20	コカイン異性体の合成と立体配座解析プロトンと炭素-13核磁気共鳴による研究 1982 ·The Journal of Organic Chemistry ·F. Ivy Carroll, (unknown), (unknown)	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact